Nutritional Pearls: Omega-3 Supplements and Heart Disease
John is a 52-year-old man who is concerned about his risk of heart disease and cancer. For years, John has taken omega-3 supplements every day. Recently, he heard about a study that showed that they may not have any effect on his heart disease risk and is wondering if he should keep taking them.
How would you advise your patient?
(Answer and discussion on next page)
Dr. Gourmet is the definitive health and nutrition web resource for both physicians and patients with evidence-based resources including special diets for warfarin users, patients with GERD/acid reflux, celiac disease, type 2 diabetes, low sodium diets (1500 mg/d), and lactose intolerance.
Timothy S. Harlan, MD, is a board-certified internist and professional chef who translates the Mediterranean diet for the American kitchen with familiar, healthy recipes. He is an assistant dean for clinical services, executive director of The Goldring Center for Culinary Medicine, associate professor of medicine at Tulane University in New Orleans, and faculty chair of the Certified Culinary Medicine Specialist program.
Answer: Your patients are better off eating great food rather than taking supplements
A little over a year ago, a meta-analysis of randomized, controlled trials found that for those at higher risk for heart disease, taking omega-3 fatty acid supplements had no effect on their risk of heart attack, stroke, or related events.
I concluded at the time that there was no reason to throw out the omega-3 supplements you might already have: they certainly don't seem to increase your risk of disease. That said, this research underlines the benefit of consuming our nutrients from food, rather than getting those nutrients in isolated, supplement form: better to eat the fish than take the pills.
Yet that meta-analysis was limited to those at higher risk of heart disease: participants in all 10 of the studies had a history of coronary heart disease, a previous stroke, or diabetes. What about those whose risk isn't elevated? Would omega-3 supplements benefit them?
The Research
Researchers at Harvard recently published the results of a 5-year randomized controlled trial that compared omega-3 fatty acid supplements of 1 gram of omega-3 fatty acids per day with placebo. Over 25,000 people participated in the trial: participants were at least 50 years of age (for men) or 55 (for women). About half of all participants were taking medication for high cholesterol, half taking medication for high blood pressure, and about 13% were diabetic.
After an average of 5.3 years (due to rolling start and end dates), the authors compared the rates of cardiovascular events and cancer diagnoses between the participants taking the placebo and those taking the omega-3 supplements.
The Results
Overall, those taking the omega-3 supplements did not experience heart attack, stroke, or death from another cardiovascular cause at higher rates than the group taking a placebo. Oddly enough, those taking the supplements were more likely to develop prostate or colorectal cancer (15% and 23% increase in risk, respectively). However, overall risk of death from "a major cardiovascular event" was still cut by 11%, risk of death from heart attack was cut by 18%, and risk from any cause whatsoever reduced by an amount considered clinically insignificant.
The authors also assessed the risk of cancers, overall, finding that the risk of "invasive cancer of any type" was increased by 13% among those taking the omega-3 supplements, while their overall risk of death from cancer decreased by 7%.
What’s the Take Home?
Once again, your patients are better off eating great food rather than taking supplements, even if they are allergic to their primary form (such as omega-3 fatty acids for those who are allergic to fish or shellfish). For those who are allergic to fish or shellfish, alternatives include walnuts, ground chia or flax seeds, canola oil, spinach, and kidney beans.
References:
- Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks. JAMA Cardiol. 2018;3(3):225-233.
- Manson J, Cook N, Lee I, et al. Marine n−3 Fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019; 380:23-32